Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Epidemiology, Biomarkers & Prevention
Cancer Epidemiology, Biomarkers & Prevention
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CEBP Focus Archive
    • Meeting Abstracts
    • Progress and Priorities
    • Collections
      • COVID-19 & Cancer Resource Center
      • Disparities Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Informing Public Health Policy
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Research Articles

Extent of Alcohol Consumption among Adult Survivors of Childhood Cancer: The British Childhood Cancer Survivor Study

Clare Frobisher, Emma R. Lancashire, Raoul C. Reulen, David L. Winter, Michael C.G. Stevens and Michael M. Hawkins
Clare Frobisher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emma R. Lancashire
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raoul C. Reulen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David L. Winter
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael C.G. Stevens
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael M. Hawkins
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1055-9965.EPI-10-0006 Published May 2010
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Tables

  • Table 1.

    Frequency of current drinkers and corresponding ORs (99% CIs) from multivariable logistic regression for the significant or borderline significant explanatory factors for being a current drinker

    FactorTotal no. survivors% Current drinkerORs for being a current drinker (99% CI)Pheterogeneity*Ptrend (Pnonlinearity)†
    Overall10,38977.2%
    Gender
        Males5,30779.6%1.00
        Females5,08274.8%0.70 (0.57-0.87)<0.001
    Radiotherapy
        No2,209‡82.5%1.00
        Radiotherapy to non (abdominal/pelvic/brain) site1,281‡86.3%1.21 (0.82-1.78)
        Radiotherapy to abdominal and pelvic region983‡84.1%0.93 (0.61-1.41)
        Radiotherapy to brain2,941‡73.8%0.70 (0.49-0.99)0.022
    SEC§
        Managerial and professional occupations2,320‡90.3%1.00
        Intermediate occupations1,828‡84.6%0.88 (0.63-1.21)
        Routine and manual occupations3,173‡81.4%0.83 (0.61-1.13)0.071 (0.775)∥
        Never worked and unemployed606‡64.0%0.49 (0.31-0.76)
        Student1,732‡59.0%0.34 (0.22-0.52)<0.001
    Legal marital status
        Single6,823‡73.8%1.00
        Married2,715‡84.5%1.17 (0.90-1.52)
        Separated/widowed/divorced622‡83.9%1.63 (1.05-2.54)0.012
    Region¶
        England
        London952‡72.4%1.00
        North East477‡78.2%1.95 (1.10-3.46)
        North West1,246‡77.1%1.51 (1.00-2.29)
        Yorkshire and the Humber889‡78.0%1.75 (1.10-2.79)
        East Midlands794‡77.0%1.88 (1.17-3.03)
        West Midlands952‡74.1%1.41 (0.91-2.19)
        East of England1,105‡78.5%1.59 (1.06-2.39)
        South East1,509‡79.9%1.75 (1.18-2.58)
        South West1,045‡79.2%1.62 (1.05-2.48)
        Wales515‡79.4%2.51 (1.40-4.51)
        Scotland894‡75.3%1.61 (1.02-2.52)0.003
    Level of educational attainment**
        No qualifications1,545‡55.0%1.00
        Level 14,191‡77.4%1.63 (1.20-2.21)
        Level 22,879‡84.9%2.20 (1.56-3.11)
        Level 31,430‡90.2%2.28 (1.49-3.52)<0.001<0.001 (0.045)
    Third party completed the questionnaire
        No9,09181.2%1.00
        Yes1,29849.8%0.60 (0.44-0.83)<0.001
    Physical function score††
        Low999‡55.2%1.00
        Moderate3,968‡76.5%1.30 (0.90-1.88)
        High5,010‡83.6%1.70 (1.11-2.60)0.002<0.001 (0.950)
    Social functioning score††
        Low1,073‡58.6%1.00
        Moderate3,069‡76.5%1.25 (0.86-1.81)
        High5,994‡81.9%1.58 (1.03-2.43)0.0150.004 (0.940)
    • ↵*The P value (two-sided) is from the likelihood ratio test for heterogeneity in the probability of being a current alcohol drinker across different levels of the specified explanatory factor with adjustment for all other factors in the multivariable model. The threshold for statistical significance was 0.01.

    • ↵†The Ptrend is from the test for trend and the P value in parentheses is from the test for departure from a linear trend. Both P values are two-sided. The threshold for statistical significance was 0.01.

    • ↵‡These values do not add up to the total because of exclusion of those with no record of treatment (radiotherapy, n = 2,975) and unusable or missing data (SEC: missing data or occupations given were inadequately described or could not be used to classify SEC, n = 730; legal marital status: missing data, n = 229; region: survivors who lived in Northern Ireland or the Channel Islands, n = 11, were excluded from the analysis; educational attainment: missing data, n = 344; physical function score: missing data, n = 412; social functioning score: missing data, n = 253).

    • ↵§For SEC, the survivor's present or most recent occupation was used to classify survivors into “managerial and professional occupations,” “intermediate occupations,” or “routine and manual occupations” defined by the 2002 General Household Survey (14); two further categories were added: “student” and “never worked or unemployed” due to the BCCSS population characteristics.

    • ↵∥For SEC, the tests for trend and for departure from a linear trend were completed using the first three levels of the factor: managerial and professional, intermediate, and routine and manual occupations.

    • ↵¶Region was based on government office regions in Great Britain (14) and was established using the survivor's address at questionnaire completion or, if not available, the location of their registered general practitioner.

    • ↵**The different levels for educational attainment relate to formal educational qualifications in Great Britain, which include level 1, which corresponds to a low level of qualification obtained in Great Britain (e.g., General Certificate of Standard Education); level 2, which corresponds to an intermediate level of educational attainment (e.g., Advanced level qualification); and level 3, the highest level of qualification, a first degree or higher.

    • ↵††The score categories were for physical function (low, 0-45; moderate, 46-99; high, 100) and social functioning (low, 0-44; moderate, 45-99; high, 100); see Materials and Methods for explanation on defining these categories.

  • Table 2.

    Frequency of survivors consuming over the weekly drinking recommendations and corresponding ORs (99% CIs) from multivariable logistic regression for the significant or borderline significant explanatory factors for consuming over recommended levels

    FactorTotal no. current drinkersPercentage consuming over recommended levels*ORs (99% CI)Pheterogeneity†Ptrend (Pnonlinearity)‡
    Overall7,973§23.8%
    Gender
        Males4,18927.7%1.00
        Females3,78419.5%0.65 (0.53-0.79)<0.001
    Age at questionnaire completion (y)
        16-242,60226.1%1.00
        25-342,92222.9%0.71 (0.53-0.94)
        35-441,65123.1%0.85 (0.59-1.22)
        45-5465721.0%0.84 (0.52-1.36)
        ≥5514121.3%0.81 (0.37-1.77)0.0170.057 (0.039)
    Radiotherapy
        No1,810∥24.3%1.00
        Radiotherapy to non (abdominal/pelvic/brain) site1,099∥25.5%1.00 (0.72-1.38)
        Radiotherapy to abdominal and pelvic region826∥23.9%0.97 (0.67-1.41)
        Radiotherapy to brain2,149∥20.4%0.63 (0.44-0.91)0.013
    Legal marital status
        Single4,994∥26.4%1.00
        Married2,286∥18.2%0.54 (0.42-0.70)
        Separated/widowed/divorced519∥24.3%0.80 (0.55-1.16)<0.001
    Third party completed the questionnaire
        No7,34424.7%1.00
        Yes62913.2%0.52 (0.33-0.83)<0.001
    Whether receiving long-term regular hospital follow-up¶
        No4,992∥24.6%1.00
        Yes2,732∥22.6%0.82 (0.66-1.02)0.018
    General health perception score**
        Low681∥23.2%1.00
        Moderate2,958∥26.1%1.09 (0.73-1.63)
        High4,195∥22.4%0.83 (0.53-1.30)0.0100.019 (0.057)
    Mental health score**
        Low1,218∥26.9%1.00
        Moderate2,192∥22.4%0.63 (0.45-0.86)
        High4,401∥24.0%0.63 (0.45-0.90)<0.0010.007 (0.007)
    • ↵*This includes all current drinkers who reported weekly alcohol units of >21 units for men and >14 units for women.

    • ↵†The P value (two-sided) is from the likelihood ratio test for heterogeneity in the probability of consuming over the recommended weekly alcohol units across different levels of the specified explanatory factor with adjustment for all other factors in the multivariable model, using only the current drinkers. The threshold for statistical significance was 0.01.

    • ↵‡The Ptrend is from the test for trend and the P value in parentheses is from the test for departure from a linear trend. Both P values are two-sided. The threshold for statistical significance was 0.01.

    • ↵§This is not all current drinkers (n = 8,024) due to missing alcohol units for 51 survivors.

    • ↵∥These values do not equal the total because of exclusion of those with no record of treatment (radiotherapy n = 2,089) and unusable or missing data (legal marital status: missing data, n = 174; whether receiving long-term regular hospital follow-up: missing data, n = 249; general health perception score: missing data, n = 139; mental health score: missing data, n = 162).

    • ↵¶Information obtained from the consent form returned from the general practitioner, which asked whether the survivor was receiving long-term regular hospital follow-up in relation to his/her childhood neoplastic disease.

    • ↵**The score categories were for general health perception (low, 0-32; moderate, 33-76; high, 77-100) and mental health (low, 0-52; moderate, 53-75; high, 76-100).

  • Table 3.

    Frequency of survivors consuming harmful amounts of alcohol and corresponding ORs (99% CIs) from multivariable logistic regression for the significant or borderline significant explanatory factors for consuming harmful amounts

    FactorTotal no. current drinkersPercentage consuming harmful amounts of alcohol*ORs (99% CI)Pheterogeneity†Ptrend (Pnonlinearity)‡
    Overall7,973§3.9%
    Gender
        Males4,1895.0%1.00
        Females3,7842.8%0.39 (0.23-0.66)<0.001
    Legal marital status
        Single4,994∥4.4%1.00
        Married2,286∥2.5%0.50 (0.26-0.96)
        Separated/widowed/divorced519∥5.0%1.16 (0.52-2.59)0.004
    Level of educational attainment
        No qualifications841∥5.5%1.00
        Level 13,223∥4.5%0.77 (0.37-1.60)
        Level 22,433∥3.7%0.66 (0.30-1.47)
        Level 31,288∥1.5%0.25 (0.08-0.78)0.0060.003 (0.179)
    • ↵*This includes all current drinkers who reported weekly alcohol units of >50 units for men and >35 units for women.

    • ↵†The P value (two-sided) is from the likelihood ratio test for heterogeneity in the probability of consuming harmful weekly amounts of alcohol, across different levels of the specified explanatory factor with adjustment for all other factors in the multivariable model, using only the current drinkers. The threshold for statistical significance was 0.01.

    • ↵‡The Ptrend is from the test for trend and the P value in parentheses is from the test for departure from a linear trend. Both P values are two-sided. The threshold for statistical significance was 0.01.

    • ↵§This is not all current drinkers (n = 8,024) due to missing alcohol units for 51 survivors.

    • ↵∥These values do not equal the total because of unusable or missing data (legal marital status: missing data, n = 174; educational attainment: missing data, n = 188).

  • Table 4.

    Comparison of the prevalence of current drinkers among survivors and the general population of Britain, overall and for childhood cancer and treatment subgroups, with ORs and 99% CIs from a multivariable GEE logistic regression model

    Childhood cancer type group and treatment subgroup where relevantNumbers usedPercentage of current drinkers*OR (99% CI)†
    GHS (reference)12,618‡86.2%‡1.00
    All survivors10,387§77.2%0.52 (0.46-0.60)
        Brain irradiated2,941∥73.8%0.46 (0.39-0.55)
        Brain not irradiated4,471∥84.0%0.71 (0.61-0.83)
    CNS neoplasm2,18267.4%0.34 (0.29-0.41)
        Brain irradiated1,009∥62.9%0.29 (0.23-0.37)
        Brain not irradiated704∥76.4%0.49 (0.37-0.65)
    Leukemia2,84975.5%0.50 (0.42-0.61)
        Brain irradiated1,878∥79.9%0.61 (0.49-0.75)
        Brain not irradiated163∥84.0%0.68 (0.38-1.23)
    Hodgkin's lymphoma73586.0%0.70 (0.51-0.95)
    Non–Hodgkin's lymphoma53584.9%0.71 (0.50-1.02)
    Neuroblastoma42475.9%0.51 (0.36-0.72)
    Wilms' tumor96681.2%0.69 (0.53-0.90)
    Bone sarcomas39786.6%0.83 (0.53-1.30)
    Soft tissue sarcomas71683.2%0.70 (0.51-0.95)
    Retinoblastoma70380.5%0.59 (0.44-0.79)
    Other neoplasms¶88079.9%0.58 (0.45-0.75)
    • ↵*These percentages will be very slightly different to those reported in Table 1 because we used survivors aged ≤69 years for this external comparison.

    • ↵†From a GEE multivariable logistic regression controlling for age at questionnaire completion (only those aged up to and including 69 years were included because educational attainment was only requested from individuals aged up to and including 69 years in the GHS), gender, legal marital status, SEC, educational attainment, and region, and took into account the GHS weighting factor, for the likelihood of being a current drinker.

    • ↵‡These are the unweighted values from the GHS. Using the GHS weighting factor, the weighted percentage of current drinkers from the GHS was 86.0%.

    • ↵§This does not include the total number of survivors for whom we have current drinking data; two survivors were excluded from this analysis due to being aged >69 years at questionnaire completion.

    • ↵∥These do not sum the total number of survivors used because the category “brain not irradiated” does not include the survivors for whom we have no record of their radiotherapy; this was for all survivors (n = 2,975), for CNS neoplasm survivors (n = 469), and for leukemia survivors (n = 808).

    • ↵¶Other neoplasms include Burkitt's lymphomas; intracranial and intraspinal germ cell tumors; gonadal germ cell tumors; other and unspecified nongonadal germ cell tumors; thyroid carcinomas; and malignant melanoma, skin carcinoma, and other less frequently occurring carcinomas.

  • Table 5.

    Comparison of the prevalence of current drinkers consuming over the weekly drinking recommendations, and consuming harmful weekly amounts of alcohol, among survivors and the general population of Britain, overall and for childhood cancer and treatment subgroups, with ORs and 99% CIs from multivariable GEE logistic regression models

    Childhood cancer type group and treatment subgroup where relevantNumbers used*Consuming over recommendationsConsuming harmful amounts of alcohol
    Percentage*OR (99% CI)†Percentage*OR (99% CI)†
    GHS (referent)10,868‡25.9%‡1.006.0%‡1.00
    All survivors7,97223.8%0.65 (0.58-0.73)3.9%0.40 (0.32-0.49)
        Brain irradiated2,149§20.4%0.52 (0.43-0.62)2.6%0.24 (0.16-0.36)
        Brain not irradiated3,734§24.6%0.78 (0.69-0.89)3.8%0.47 (0.36-0.61)
    CNS neoplasm1,45719.1%0.50 (0.41-0.62)3.0%0.33 (0.21-0.51)
        Brain irradiated628§15.0%0.38 (0.27-0.53)1.9%0.21 (0.09-0.48)
        Brain not irradiated535§23.9%0.75 (0.56-1.02)3.0%0.37 (0.19-0.74)
    Leukemia2,13522.3%0.54 (0.45-0.64)3.5%0.30 (0.21-0.43)
        Brain irradiated1,487§22.9%0.58 (0.48-0.71)2.9%0.26 (0.16-0.41)
        Brain not irradiated136§19.9%0.55 (0.29-1.04)3.7%0.30 (0.06-1.42)
    Hodgkin's lymphoma62933.2%1.10 (0.86-1.40)4.3%0.44 (0.25-0.79)
    Non–Hodgkin's lymphoma45229.0%0.81 (0.60-1.10)5.5%0.52 (0.28-0.94)
    Neuroblastoma31923.5%0.59 (0.40-0.87)3.8%0.38 (0.17-0.86)
    Wilms' tumor78427.7%0.83 (0.66-1.05)4.3%0.47 (0.29-0.77)
    Bone sarcomas34121.7%0.62 (0.43-0.91)4.7%0.61 (0.30-1.24)
    Soft tissue sarcomas59227.7%0.78 (0.60-1.03)6.8%0.74 (0.46-1.19)
    Retinoblastoma56421.3%0.64 (0.48-0.86)3.2%0.39 (0.20-0.76)
    Other neoplasms69922.2%0.64 (0.49-0.84)3.3%0.36 (0.19-0.66)
    • ↵*The totals and percentages were calculated for survivors aged ≤69 years.

    • ↵†From a GEE multivariable logistic regression model controlling for age at questionnaire completion (≤69 years), gender, legal marital status, SEC, educational attainment, and region, and took into account the GHS weighting factor, for the likelihood of consuming over the recommendations for weekly alcohol units or consuming harmful weekly amounts of alcohol.

    • ↵‡These are the unweighted values from the GHS. Using the GHS weighting factor, the weighted percentage of those consuming over recommended levels and consuming harmful weekly amounts of alcohol from the GHS were 26.6% and 6.3%, respectively.

    • ↵§These do not sum the total number of survivors used because the category brain not irradiated does not include the survivors for whom we have no record of their radiotherapy; this was for all survivors (n = 2,089), for CNS neoplasm survivors (n = 294), and for leukemia survivors (n = 512).

PreviousNext
Back to top
Cancer Epidemiology Biomarkers & Prevention: 19 (5)
May 2010
Volume 19, Issue 5
  • Table of Contents
  • Table of Contents (PDF)

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Epidemiology, Biomarkers & Prevention article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Extent of Alcohol Consumption among Adult Survivors of Childhood Cancer: The British Childhood Cancer Survivor Study
(Your Name) has forwarded a page to you from Cancer Epidemiology, Biomarkers & Prevention
(Your Name) thought you would be interested in this article in Cancer Epidemiology, Biomarkers & Prevention.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Extent of Alcohol Consumption among Adult Survivors of Childhood Cancer: The British Childhood Cancer Survivor Study
Clare Frobisher, Emma R. Lancashire, Raoul C. Reulen, David L. Winter, Michael C.G. Stevens and Michael M. Hawkins
Cancer Epidemiol Biomarkers Prev May 1 2010 (19) (5) 1174-1184; DOI: 10.1158/1055-9965.EPI-10-0006

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Extent of Alcohol Consumption among Adult Survivors of Childhood Cancer: The British Childhood Cancer Survivor Study
Clare Frobisher, Emma R. Lancashire, Raoul C. Reulen, David L. Winter, Michael C.G. Stevens and Michael M. Hawkins
Cancer Epidemiol Biomarkers Prev May 1 2010 (19) (5) 1174-1184; DOI: 10.1158/1055-9965.EPI-10-0006
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Disclosure of Potential Conflicts of Interest
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Estimated Effects of Multi-Cancer Screening
  • Gene–Environment Interaction Portfolio Analysis
  • Risk Prediction for Renal Cell Carcinoma
Show more Research Articles
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook   Twitter   LinkedIn   YouTube   RSS

Articles

  • Online First
  • Current Issue
  • Past Issues

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Epidemiology, Biomarkers & Prevention

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Epidemiology, Biomarkers & Prevention
eISSN: 1538-7755
ISSN: 1055-9965

Advertisement